<--- Back to Details
First PageDocument Content
Genentech / Hoffmann-La Roche / South San Francisco /  California / Biotechnology / CSL Behring / Dharamsinh Desai University / California / Economy of the United States
Date: 2014-01-22 12:11:12
Genentech
Hoffmann-La Roche
South San Francisco
California
Biotechnology
CSL Behring
Dharamsinh Desai University
California
Economy of the United States

Biomedical/ Biotechnology/ Biopharmaceuticals B iomedical/B iotechnology/B iopharmaceuticals

Add to Reading List

Source URL: www.cslbehring.com

Download Document from Source Website

File Size: 2,68 MB

Share Document on Facebook

Similar Documents

TAMIFLU - oseltamivir phosphate powder, for suspension TAMIFLU - oseltamivir phosphate capsule Hoffmann-La Roche Inc DESCRIPTION TAMIFLU (oseltamivir phosphate) is available

DocID: 1v09s - View Document

Panel II: SMA Drugs in Development • Thomas Blaettler MD, Global Clinical Development Team Leader, F. Hoffmann-La Roche • Lawrence Charnas, MD, PhD, Sr. Translational Medicine Expert, Musculoskeletal Diseases, Novart

DocID: 1sY97 - View Document

Panel II: SMA Drugs in Development • Jinsy Andrews MD, Director of Clinical Research and Development, Cytokinetics • Thomas Blaettler MD, Global Clinical Development Team Leader, F. Hoffmann-La Roche • Jerry R. Men

DocID: 1sY50 - View Document

FERCAP Conference Empowering Stakeholders in Health Research: Towards Developing an Ethics of Accountability and Responsibility Beat Widler, F. Hoffmann-La Roche Bangkok , Thailand

DocID: 1sI6G - View Document

Medicine / Clinical medicine / Chemistry / Lactones / Enzyme inhibitors / Formamides / Aldehydes / Hoffmann-La Roche / Orlistat / Anti-obesity medication / Adverse effect / Sibutramine

orlistat and pcoc orlistat 60 mg studies persistence analysis sibutramine orlistat, clinical studies orlistat, orlistat and gall stones does orlistat work, health problems and orlistat orlistat and appetite. orlistat pre

DocID: 1rrCO - View Document